GGrantIndex
← Leaderboards

Lisa M. Demeter

University Of Rochester

$4,404,327
Attributed
$4,404,327
Total exposure
7
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $864K · FY200511
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$4,404,327 · 7

By mechanism

R01$3,348,202 · 2
P30$648,389 · 1
R21$239,250 · 1
M01$168,486 · 3

Top collaborators

No co-investigators on record.

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchBaseDrug ResistanceVirus ReplicationEfavirenzRna Directed Dna PolymeraseResearch PersonnelFlow CytometryDesignGenetic PolymorphismHuman Immunodeficiency Virus 1Dna FootprintingRibonuclease HGene MutationTissue /Cell CultureReverse Transcriptase InhibitorsAids TherapyActive SitesBehavioralFitnessClinically SignificantDrug Screening /EvaluationChemical CleavageAntiviral Agents

Grant awards (19)

Virology/Immunology Core$239,818
P30 · FY2011 · AI · contact PI
Virology/Immunology Core$122,193
P30 · FY2010 · AI · contact PI
Virology/Immunology Core$164,666
P30 · FY2009 · AI · contact PI
Clinical Significance of HIV Replication Fitness$371,495
R01 · FY2008 · AI · contact PI
Impact of NNRTI-resistance on RNase H & HIV replication$370,764
R01 · FY2008 · AI · contact PI
Virology/Immunology Core$121,712
P30 · FY2008 · AI · contact PI
Clinical Significance of HIV Replication Fitness$378,690
R01 · FY2007 · AI · contact PI
Impact of NNRTI-resistance on RNase H & HIV replication$375,360
R01 · FY2007 · AI · contact PI
Clinical Significance of HIV Replication Fitness$384,568
R01 · FY2006 · AI · contact PI
Impact of NNRTI Resistance on RNase H &HIV Replication$319,000
R01 · FY2005 · AI
ACTG 317: TRIAL OF QUADRUPLE DRUG INDUCTION TREATMENT IN PT W/ ACUTE HIV INFECT$49,619
M01 · FY2005 · RR
ACTG A5146: IMPACT OF THERAPEUTIC DRUG MONITORING IN SALVAGE REGIMENS$39,093
M01 · FY2005 · RR
DONATION OF ONE UNIT OF BLOOD$16,539
M01 · FY2005 · RR
Impact of NNRTI Resistance on RNase H &HIV Replication$319,000
R01 · FY2004 · AI
DONATION OF ONE UNIT OF BLOOD$63,235
M01 · FY2004 · RR
Impact of NNRTI Resistance on RNase H &HIV Replication$319,000
R01 · FY2003 · AI
Impact of NNRTI Resistance on RNase H &HIV Replication$319,000
R01 · FY2002 · AI
Impact of NNRTI Resistance on RNase H &HIV Replication$239,250
R21 · FY2001 · AI
DLV RESISTANCE MUTATIONS IN HIV REPLICATIONS$191,325
R01 · FY2000 · AI